Slagle Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
2,270
-66
| -3% | -$7.32K | 0.1% | 99 |
|
|
2025
Q1 | $262K | Sell |
2,336
-25,788
| -92% | -$2.89M | 0.12% | 88 |
|
|
2024
Q4 | $2.6M | Buy |
28,124
+1,100
| +4% | +$102K | 1.17% | 32 |
|
|
2024
Q3 | $2.27M | Buy |
27,024
+1,347
| +5% | +$113K | 1.01% | 40 |
|
|
2024
Q2 | $1.76M | Buy |
25,677
+1,055
| +4% | +$72.4K | 0.9% | 49 |
|
|
2024
Q1 | $1.8M | Sell |
24,622
-26,508
| -52% | -$1.94M | 0.98% | 44 |
|
|
2023
Q4 | $2.07M | Buy |
51,130
+25,438
| +99% | +$1.03M | 1.19% | 37 |
|
|
2023
Q3 | $1.93M | Buy |
25,692
+1,227
| +5% | +$92K | 1.18% | 31 |
|
|
2023
Q2 | $1.89M | Buy |
+24,465
| New | +$1.89M | 1.17% | 35 |
|